Press Releases

SMi Group reports: If you are involved in paediatric clinical trials then SMi Groups Paediatric Clinical Trials conference, is a must attend event…and here is why… If you are looking…
Read More...

Aldevron, a provider of contract plasmid DNA manufacturing, protein production and antibody discovery services, and Integrated DNA Technologies, Inc. (IDT), a supplier of custom nucleic…
Read More...

PAREXEL International Corporation introduced the Perceptive Cloud to the life sciences industry, as part of the organization’s recent alliance with Microsoft Corp. Perceptive Cloud…
Read More...

SMi are delighted to welcome Oliver Rausch, VP Research & Development, Storm Therapeutics, onto the speaker line-up for day 1 at RNA Therapeutics 2018! Oliver has overall…
Read More...

Immuneed, a Swedish life science biotech company, today announced the publication of two key scientific publications, supporting both its immuno-service and its immuno-oncology…
Read More...

Gilead Sciences and its cell therapy subsidiary Kite announced that they have entered into a definitive agreement under which they have agreed to acquire Cell Design Labs, Inc., gaining…
Read More...

SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticalsonto the speaker panel RNA Therapeutics 2018! Dr. James…
Read More...

SMi reports: Andrew Hopkins, Chief Executive at Exscientia to discuss the role of Artificial Intelligence in small molecule drug discovery at SMi’s Drug Discovery conference in March…
Read More...

Learn More About: How to map out and understand a patient’s journey Creating powerful pharmaceutical social media strategies Understanding customer conversations online How…
Read More...

Proteome Sciences are pleased to announce the receipt of Good Clinical Laboratory Practice (GCLP) accreditation which will enable the Company to extend its proteomic services to the…
Read More...

SMi reports: ReykHorland, Vice President, Business Development at TissUse GmbH to discuss “Applying Multi-Organ-on-a-Chip Technologies for Predictive Substance Testing" at SMi’s Drug…
Read More...

Now running for 10 years, SMi Group’s annual conference on Adaptive Designs in Clinical Trials returns to London in Spring 2018, gathering a senior audience of experts to discuss and…
Read More...

SMI REPORTS: Expert insight into tackling the scientific, regulatory and economic challenges to combat antimicrobial resistance. It is imperative for medical experts and drug…
Read More...

SMi are thrilled to welcome Adam Doggett, Senior Research Analyst, CREATION onto the speaker panel for their 10th annual Social Media in Pharma conference! Adam's expertise lies in…
Read More...

SMi reports: Abbvie and Astrazeneca to present keynote address’ at SMi’s Drug Discovery conference taking place in London on 21st-22nd March 2018 Abbvie and Astrazeneca will present…
Read More...

A spotlight on patient needs in parenteral drug delivery SMi Group will focus on patient needs in parenteral drug delivery in an exclusive spotlight at the 10th annual Pre-Filled…
Read More...

Technology encapsulates our everyday lives, nowhere is this more obvious than in healthcare, where technology goes beyond convenience, it is helping to save lives. At MEDICAL FAIR ASIA…
Read More...

Social Media in the Pharmaceutical Industry conference will be bringing a global presence from GSK, Pfizer, IBM, Janssen, Roche Diabetes Care, Bristol-Myers Squibb, MSD, ABPI, and more.…
Read More...

SMi are delighted to have, Nagy Habib, Head of HPB Surgery, Imperial College London and Co-Founder, MiNA Therapeutics, as the Keynote Address for day 1 at RNA Therapeutics 2018!…
Read More...

Generic drug manufacturers can pose major financial threats to the companies that invent and develop the copied drugs both domestically and internationally. Even after a pharmaceutical…
Read More...